Bispecific Single Chain Antibodies With Specificity For High Molecular Weight Target Antigens

Patent No. EP2352763 (titled "Bispecific Single Chain Antibodies With Specificity For High Molecular Weight Target Antigens") was filed by Amgen Research Munich on Oct 1, 2009. The application was issued on Sep 21, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JANSSEN BIOTECHJan 12, 2017CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2352763

AMGEN RESEARCH MUNICH
Application Number
EP09736398A
Filing Date
Oct 1, 2009
Status
Patent Maintained As Amended
Aug 19, 2022
Publication Date
Sep 21, 2022